Tower Cancer Research Foundation, Beverly Hills
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
Cedars-Sinai Medical Center, Los Angeles
și încă 1

În curs de recrutareFaza 2

Vârste de 18 ani și peste · Toate sexele · Actualizat 2 oct. 2026 · NCT05673148

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
PCR Oncology, Arroyo Grande
AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
și încă 20

În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți

Vârste de la 40 la 75 · Toate sexele · Actualizat 2 oct. 2026 · NCT05334069

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #59, Santa Barbara

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 1 oct. 2026 · NCT05176483

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

City of Hope Comprehensive Cancer Center, Duarte
University of California Los Angeles, Los Angeles
University of California San Diego Moores Cancer Center, San Diego

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 1 oct. 2026 · NCT06625775

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

The Oncology Institute of Hope and Innovation, Cerritos
Ellison Medical Institute, Los Angeles
Valkyrie Clinical Trials, Los Angeles
și încă 3

În curs de recrutareFaza 1/2

Vârste de 18 ani și peste · Toate sexele · Actualizat 30 sept. 2026 · NCT06324357

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

ALX Center 9, La Jolla
ALX Center 11, Santa Monica

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 30 sept. 2026 · NCT07085091

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Research Site, Duarte
Research Site, Los Angeles
Research Site, Newport Beach
și încă 1

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 29 sept. 2026 · NCT05877599

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 29 sept. 2026 · NCT05803382

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

UCSF at Berkeley Outpatient Center, Berkeley
Alta Bates Summit Medical Center-Herrick Campus Comprehensive Cancer Center, Berkeley
UCSD Medical Center - Encinitas, Encinitas
și încă 21

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 28 sept. 2026 · NCT07222800

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
USC Norris Comprehensive Cancer Center, Los Angeles

În curs de recrutareFaza 1/2

Vârste de 18 ani și peste · Toate sexele · Actualizat 28 sept. 2026 · NCT05482893

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

City of Hope National Medical Center /ID# 270255, Duarte
UCLA - Santa Monica /ID# 270621, Santa Monica

În curs de recrutareFaza 2

Vârste de 18 ani și peste · Toate sexele · Actualizat 28 sept. 2026 · NCT06820463

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

UCLA ( Site 0317), Los Angeles

În curs de recrutareFaza 1/2

Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT06428409

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

CBCC Global Research, Bakersfield
Los Angeles Cancer Network, Glendale
Cancer and Blood Specialty Clinic, Los Alamitos
și încă 4

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT06750094

Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial

City of Hope Comprehensive Cancer Center, Duarte
City of Hope at Irvine Lennar, Irvine

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT07271355

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

University of California San Diego, La Jolla
Stanford University, Palo Alto
UCLA Medical Center, Santa Monica

În curs de recrutareStudiu observațional

Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT04981119

A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer

University of California, Los Angeles UCLA, Los Angeles

În curs de recrutareFaza 1/2

Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT05379595

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Research Site, Duarte
Research Site, Los Angeles
Research Site, Newport Beach

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT06218914

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

CBCC Global Research, Bakersfield
Los Angeles Cancer Network, Glendale
Cancer and Blood Specialty Clinic, Los Alamitos
și încă 4

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT06662786

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

City of Hope Cancer Center, Duarte
City of Hope at Irvine Lennar, Irvine
START Los Angeles, Los Angeles

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT06004245

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Precision NextGen Oncology, Beverly Hills
OPN Healthcare, Inc, Glendale
University of Southern California, Los Angeles

În curs de recrutareFaza 1/2

Vârste de 18 ani și peste · Toate sexele · Actualizat 24 sept. 2026 · NCT06047379

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Kivu Trial Site, Santa Monica

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 24 sept. 2026 · NCT07229313

Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

UC Irvine Health Cancer Center-Newport, Costa Mesa
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
USC / Norris Comprehensive Cancer Center, Los Angeles
și încă 1

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 23 sept. 2026 · NCT06102902

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

USC/Norris Comprehensive Cancer Center, Los Angeles
University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
Local Institution - 0317, San Francisco

În curs de recrutareFaza 2/3

Vârste de 18 ani și peste · Toate sexele · Actualizat 23 sept. 2026 · NCT07221357

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Research Site, Los Angeles
Research Site, Santa Rosa

În curs de recrutareFaza 2

Vârste de la 18 la 130 · Toate sexele · Actualizat 23 sept. 2026 · NCT05489211

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

City of Hope, Duarte
University of California, Los Angeles (UCLA), Santa Monica
Stanford University Medical Center, Stanford

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Hoag Memorial Hospital Presbyterian, Newport Beach
Stanford University Medical Center, Stanford

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07213791

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

UC San Diego Moores Cancer Center, La Jolla
Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
UCLA Hematology/Oncology- Santa Monica, Los Angeles

În curs de recrutareFaza 1/2

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT06445062

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

UC IRVINE Health, Orange
UC Davis Comprehensive Cancer Center, Sacramento
Stanford Cancer Institute, Stanford

În curs de recrutareFaza 1/2

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT06128551

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

The Angeles clinic - A cedars SINAI AFFILIATE, Los Angeles
USC Norris Comprehensive Cancer Center, Los Angeles
University of California, San Francisco (UCSF), San Francisco

În curs de recrutareFaza 1/2

Vârste de 18 ani și peste · Toate sexele · Actualizat 16 sept. 2026 · NCT05786924

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Memorial Care Orange Coast Medical Center, Fountain Valley
Providence Medical Foundation, Fullerton
Cancer & Blood Research Center, Los Alamitos
și încă 1

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 15 sept. 2026 · NCT07284849

A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

City of Hope Comprehensive Cancer Center, Duarte
Cedars-Sinai Medical Center, Los Angeles
UCLA, Los Angeles

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 11 sept. 2026 · NCT04929223

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

USC/Norris Comprehensive Cancer Center, Los Angeles

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 9 sept. 2026 · NCT06440005

Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.